Procept BioroboticsPRCT
About: PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
Employees: 756
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
106% more first-time investments, than exits
New positions opened: 64 | Existing positions closed: 31
53% more repeat investments, than reductions
Existing positions increased: 115 | Existing positions reduced: 75
29% more call options, than puts
Call options by funds: $19.5M | Put options by funds: $15.1M
11% more funds holding
Funds holding: 247 [Q3] → 275 (+28) [Q4]
11% more capital invested
Capital invested by funds: $3.65B [Q3] → $4.05B (+$402M) [Q4]
4.93% more ownership
Funds ownership: 88.08% [Q3] → 93.01% (+4.93%) [Q4]
13% less funds holding in top 10
Funds holding in top 10: 8 [Q3] → 7 (-1) [Q4]
Research analyst outlook
2 Wall Street Analysts provided 1 year price targets over the past 3 months
2 analyst ratings
Truist Securities Richard Newitter 46% 1-year accuracy 22 / 48 met price target | 31%upside $70 | Buy Maintained | 11 Apr 2025 |
Morgan Stanley Patrick Wood 42% 1-year accuracy 5 / 12 met price target | 78%upside $95 | Overweight Maintained | 26 Feb 2025 |
Financial journalist opinion









